An interventional study of AVATAR Therapy in Psychosis and Hallucinations, sponsored by King's College London. Not yet recruiting at 2 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by King's College London · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 26 studies in Psychotic Disorders by King's College London — 12 open to participants now, 12 under way, none of them phase 3. Psychotic Disorders · King's College London.
Among the 26 studies in Psychotic Disorders by King's College London, this one is the 7th largest by planned enrollment of the 18 interventional ones that give a count, is one of 3 that started in 2026, is one of 15 with no phase, reaches primary completion later than 5 of the 11 other live ones, and was the 26th registered.
1,589 studies on the registry are indexed under Psychotic Disorders; 280 are open to participants now.
Browse Psychotic Disorders studies →12 of the 26 studies in Psychotic Disorders by King's College London are open now, in 3 countries. Recruiting first, the newest first:
King's College London · Sites in United Kingdom
Ages 18–65 · Healthy volunteers
King's College London · Sites in United Kingdom
Ages 18–65
King's College London · Sites in United Kingdom
Ages 18–40 · Healthy volunteers
King's College London · Sites in United Kingdom
Ages 12–35 · Healthy volunteers
King's College London · Sites in United Kingdom
Ages 18+
By country, each count listing its studies:
Of the 204 Psychotic Disorders studies recruiting now, 53 (26%) set no upper age limit and 142 (70%) stop at 75 or younger; 50 take children under 18; 41 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
26 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 1
First in 2013; this study’s year is marked. 3 started in 2026.
This study's planned enrollment of 30 is below the median of 65 across 1,321 interventional studies indexed under Psychotic Disorders.
Median enrollment 24 across the 18 interventional studies, 193 across the 8 observational. Of the 11 that completed or were terminated, 1 (9%) have results posted.
This tab as a report to print or save as PDF → With an account.
King's College London is the lead sponsor of 522 studies on the registry; 128 are open to participants now.
2 of the studies in Psychotic Disorders by King's College London that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06957808King's College LondonInvestigating the Effect of Diroximel Fumarate on Glutathione in Schizophrenia | 2027-01-20 |
| NCT07939347King's College LondonAVATAR Therapy for Distressing Voices in India and Ethiopia | 2027-09-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 26 studies in Psychotic Disorders by King's College London, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study evaluates the feasibility, acceptability, and safety of contextually adapted AVATAR therapy for people experiencing distressing voices associated with psychosis in Ethiopia and India. AVATAR therapy is a psychological intervention in which participants create a digital avatar representing a distressing voice and engage in therapist-supported dialogues with the avatar.
Thirty participants (15 in Ethiopia and 15 in India) will receive culturally adapted AVATAR therapy. Participants will complete assessments at baseline, 12 weeks, and 24 weeks. The study will assess feasibility of recruitment and retention, acceptability of the intervention, safety, and preliminary changes in voice-related distress, beliefs about voices, emotional wellbeing, and functioning. Qualitative interviews will explore participants' and therapists' experiences of the intervention and its cultural relevance.
AVATAR therapy is a psychological intervention for distressing auditory verbal hallucinations in which participants create a visual and vocal representation of a distressing voice and engage in structured dialogue with that avatar under the guidance of a trained therapist. The intervention seeks to reduce voice-related distress, improve perceived control over voices, and support recovery.
This multicentre international case series aims to evaluate the feasibility, acceptability, and safety of culturally adapted AVATAR therapy in Ethiopia and India. Adaptations have been informed by stakeholder engagement, service-user involvement, clinician feedback, and local cultural considerations.
Participants meeting eligibility criteria will complete a baseline assessment and receive up to 12 sessions of culturally adapted AVATAR therapy. Follow-up assessments will be completed at 12 weeks and 24 weeks after baseline. Quantitative measures will assess feasibility, acceptability, voice-related outcomes, emotional wellbeing, and functioning. Qualitative interviews will explore participant and therapist experiences of the intervention and identify factors relevant to future implementation and evaluation. The study is not powered to determine efficacy but will provide preliminary evidence regarding implementation and clinical outcomes in these settings.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will receive contextually adapted AVATAR therapy delivered by trained clinicians.
Behavioral: AVATAR Therapy
AVATAR therapy is a psychological intervention for distressing voices in which participants create a visual and vocal avatar representing a distressing voice and engage in structured therapist-supported dialogues. Participants attend up to 12 therapy sessions. Dialogues aim to reduce voice-related distress by targeting the relationship between the individual and the voice while promoting increased control, empowerment and recovery. Adaptations have been developed for implementation in Ethiopia and India through stakeholder engagement and cultural adaptation processes.
Recruitment feasibility
Number of participants recruited at each site within the recruitment period. Feasibility is indicated by successful recruitment of 15 participants per site.
Time frame: 9 months
Therapy completion
Proportion of participants completing the minimum therapy dose (defined as at least 4 therapy sessions involving an avatar dialogue). Feasibility target is ≥70% completion.
Time frame: Up to 12 weeks
Retention to follow-up
Proportion of participants completing 12-week and 24-week follow-up assessments.
Time frame: 24 weeks from baseline assessment
Acceptability of AVATAR Therapy: Client Satisfaction Questionnaire (CSQ-8)
Eight-item measure assessing participant satisfaction with the intervention. Scores range from 8 to 32, with higher scores indicating greater satisfaction.
Time frame: 12 weeks (end of therapy assessment)
Acceptability: Acceptability of Intervention measure (AIM) service user rating
4-item acceptability measure completed by service users. Higher scores indicate higher perceived acceptability of the intervention.
Time frame: 12 weeks (end of therapy assessment)
Safety of AVATAR therapy assessed through monitoring of adverse events
Number and nature of adverse events, serious adverse events, and intervention-related adverse events occurring during participation.
Time frame: Time Frame: Baseline to 24 weeks.
Therapist-rated intervention appropriateness
The Intervention Appropriateness Measure (IAM) is a 4-item implementation outcome measure assessing clinicians' perceptions of the fit, relevance, suitability, and appropriateness of AVATAR therapy within their clinical setting. Four items rated on a 5-point Likert scale from 1 (Completely Disagree) to 5 (Completely Agree). Higher scores indicate greater perceived appropriateness of the intervention.
Time frame: Following completion of intervention delivery (approximately 12 weeks)
Therapist-rated Feasibility of Intervention Measure (FIM)
The Feasibility of Intervention Measure (FIM) is a 4-item implementation outcome measure assessing clinicians' perceptions of the extent to which AVATAR therapy can be successfully used or carried out within their clinical setting. Four items rated on a 5-point Likert scale from 1 (Completely Disagree) to 5 (Completely Agree). Higher scores indicate greater perceived feasibility of the intervention.
Time frame: Following completion of intervention delivery (approximately 12 weeks)
Acceptability: Acceptability of Intervention measure (AIM) therapist rating
4-item acceptability measure completed by therapists. Higher scores indicate higher perceived acceptability of the intervention.
Time frame: Following completion of intervention delivery (approximately 12 weeks)
Psychotic Symptom Rating Scales - Auditory Hallucinations Subscale (PSYRATS-AH)
Clinician-rated assessment of auditory hallucination severity and associated distress. 11 items scored 0-4; higher scores indicate greater severity and distress.
Time frame: Baseline, 12 weeks, and 24 weeks.
Beliefs About Voices Questionnaire - Revised (BAVQ-R)
Assessment of beliefs and emotional/behavioural responses to voices. 35 items scored 0-3 across malevolence, benevolence, omnipotence, resistance, and engagement domains. Higher subscale scores indicate stronger endorsement of the corresponding belief or response to voices.
Time frame: Baseline, 12 weeks, and 24 weeks.
Voice Power Differential Scale
Participant rating of the relative power of the voice compared with themselves. Single-item measure scored 1-5. Higher scores indicate greater perceived power and dominance of the voice relative to the individual, whereas lower scores indicate a more balanced relationship or greater perceived personal power.
Time frame: Baseline, 12 weeks, and 24 weeks.
Patient Health Questionnaire (PHQ-9)
Self-report measure of depressive symptoms during the previous two weeks. 9 items scored 0-3; total score range 0-27, with higher scores indicating greater depression severity.
Time frame: Baseline, 12 weeks, and 24 weeks.
Generalized Anxiety Disorder-7 (GAD-7)
Anxiety symptoms assessed using the Generalized Anxiety Disorder-7 (GAD-7), a 7-item self-report measure of anxiety symptoms experienced over the previous two weeks. Participants rate how often they have been bothered by symptoms such as feeling nervous, worrying excessively, and difficulty relaxing. Total scores range from 0 to 21, with higher scores indicating greater anxiety severity.
Time frame: Baseline, 12 weeks, and 24 weeks.
World Health Organization Disability Assessment Schedule (WHODAS-12)
Self-report assessment of disability and functional impairment. 12-item measure; higher scores indicate greater disability.
Time frame: Baseline, 12 weeks, and 24 weeks.
World Health Organization Well-Being Index (WHO-5)
Self-report measure of subjective wellbeing. Five items scored 0-5; higher scores indicate greater wellbeing.
Time frame: Baseline, 12 weeks, and 24 weeks.
Sessional ratings of Voice-Related and Recovery Outcomes
Participant-completed sessional measure comprising 9 items assessing voice-related distress, voice frequency, social connection, progress towards important goals, perceived power of the voice, along with sense of voice presence and emotional responses during AVATAR therapy (including anxiety, anger, and confidence in relation to the voice dialogue). Measures are completed during each therapy session, with items 1-5 completed before the avatar dialogue and items 6-9 completed following the dialogue. Each construct is assessed using a single item and may be analysed independently. Higher scores indicate greater endorsement of the construct being measured; interpretation therefore varies according to the specific construct assessed.
Time frame: Each session during therapy (up to 12 weeks)
Goal Based Outcomes
Progress towards a participant-identified personal recovery goal. At baseline, participants identify one personally meaningful goal for therapy and rate their current progress. Progress towards this goal is subsequently rated on an 11-point scale ranging from 0 ("goal not met at all") to 10 ("goal fully achieved"). Higher scores indicate greater attainment of the participant's personal goal.
Time frame: Baseline, 12 weeks, 24 weeks
Therapeutic Alliance - Helping Alliance Questionnaire-II (HAq-II)
Therapeutic alliance assessed using the Helping Alliance Questionnaire-II (HAq-II), a 19-item participant-reported measure of the quality of the therapeutic relationship, including collaboration, trust, and perceived helpfulness of therapy. Higher scores indicate a stronger therapeutic alliance.
Time frame: 12 weeks
Service-user rated match of digital avatar to their distressing voice
Two items assessing the match between the digital avatar and their distressing voice, in terms of the voice (Q1) and image (Q2). Both are rated once after avatar creation (takes place between session 1-3) on a 0-10 scale, where a higher score indicates a more accurate representation of their distressing voice experience.
Time frame: Within 3 weeks of baseline assessment
Plan to share: Yes — De-identified individual participant data underlying the results reported in publications arising from this study may be made available to qualified researchers upon reasonable request. Requests will be reviewed by the study investigators and sponsor (King's College London) and may require appropriate ethical approvals and a data-sharing agreement. Supporting documentation including the study protocol and data dictionary may also be made available.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
Time frame: 10 years
Access criteria: De-identified individual participant data underlying the results reported in publications arising from this study may be made available to qualified researchers upon reasonable request. Requests must include a scientifically sound research proposal and evidence of appropriate institutional and ethical approvals where required. Requests will be reviewed by the study investigators and sponsor (King's College London). Data sharing may be subject to a data sharing agreement and compliance with applicable legal, ethical, and data protection requirements.
No publications or documents are linked to this record.
Start is estimated for Nov 2026; primary completion for Sep 2027, 10 months later.
Of 457 non-industry interventional studies with no phase under Psychotic Disorders, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 52. This study's planned 10 months is below that.
Counting every sponsor, half of 459 studies reached it within 34 months; a quarter within 19 and three quarters within 52.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.